ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,561Medicare Part D Prescriptions Filled, Including Refills

Rank: 104 out of 1383

$880K Total Retail Price of All Prescriptions

Rank: 83 out of 1383

558 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
57% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 558 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

16% of this provider’s 558 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 12,040 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
POTASSIUM CHLORIDE 647 495 1 12
OMEPRAZOLE 632 437 2 5
FUROSEMIDE 530 367 3 7
LEVOTHYROXINE SODIUM 478 405 4 4
SIMVASTATIN 478 377 4 2
METOPROLOL TARTRATE 399 318 6 9
HYDROCODONE-ACETAMINOPHEN 356 223 S3 7 1
ZOLPIDEM TARTRATE 344 236 8 17
ENALAPRIL MALEATE 326 214 9 75
HYDROCHLOROTHIAZIDE 299 259 10 10
AMLODIPINE BESYLATE 291 229 11 6
CRESTOR 273 180 12 34
ATORVASTATIN CALCIUM 272 217 13 18
WARFARIN SODIUM 259 224 14 13
ALLOPURINOL 251 203 15 33
RANITIDINE HCL 247 133 16 19
PRAVASTATIN SODIUM 236 174 17 14
BENAZEPRIL HCL 232 163 18 38
METFORMIN HCL 229 175 19 8
FENOFIBRATE 224 163 20 65
CARVEDILOL 188 144 21 24
SPIRONOLACTONE 181 143 22 67
LISINOPRIL 178 164 23 3
METFORMIN HCL ER 177 125 24 47
LOSARTAN POTASSIUM 176 138 25 23
MELOXICAM 173 111 26 20
TRAMADOL HCL 168 115 27 25
CLONIDINE HCL 156 108 28 44
GABAPENTIN 150 84 29 11
SERTRALINE HCL 149 109 30 21
NEXIUM 149 101 30 26
FLUOXETINE HCL 147 73 32 52
FLUTICASONE PROPIONATE 146 107 33 39
TAMSULOSIN HCL 144 104 34 30
PROAIR HFA 135 80 35 42
AZITHROMYCIN 129 91 36 41
CLOPIDOGREL 124 106 37 28
LOVASTATIN 122 108 38 22
DIOVAN 120 110 39 58
ATENOLOL 118 71 40 16
BUMETANIDE 106 101 41 122
TRIAMTERENE-HCTZ 103 59 42 48
GLIMEPIRIDE 102 95 43 31
DILTIAZEM 24HR CD 101 81 44 95
LEVOFLOXACIN 97 71 45 88
PANTOPRAZOLE SODIUM 94 65 46 32
CITALOPRAM HBR 91 75 47 15
LIPITOR 91 74 47 158
LOSARTAN-HYDROCHLOROTHIAZIDE 90 65 49 60
DONEPEZIL HCL 82 82 50 35
AMOX TR-POTASSIUM CLAVULANATE 81 54 51 106
CIPROFLOXACIN HCL 79 68 52 54
PLAVIX 78 70 53 43
METHOCARBAMOL 77 31 R 54 141
POLYETHYLENE GLYCOL 3350 76 51 55 64
JANUVIA 75 40 56 85
SINGULAIR 75 44 56 82
ADVAIR DISKUS 74 54 58 63
METOPROLOL SUCCINATE 72 51 59 29
HYDRALAZINE HCL 70 47 60 86
PAROXETINE HCL 70 49 60 55
TERAZOSIN HCL 67 53 62 111
DIGOXIN 63 63 63 59
AMOXICILLIN 61 45 64 119
LANTUS SOLOSTAR 61 56 64 112
ISOSORBIDE MONONITRATE ER 61 49 64 66
SYNTHROID 60 49 67 73
PROMETHAZINE HCL 58 25 R 68 56
NIASPAN 58 38 68 148
CEPHALEXIN 58 45 68 87
BUSPIRONE HCL 58 40 68 109
PRAMIPEXOLE DIHYDROCHLORIDE 57 42 72 160
LEVEMIR FLEXPEN 56 36 73 199
SPIRIVA 55 29 74 45
EVISTA 55 55 74 152
INSULIN SYRINGE 55 37 74 83
TRAZODONE HCL 54 41 77 36
LEVOXYL 54 44 77 206
NITROFURANTOIN 54 48 77 187
LYRICA 52 32 80 72
FLUCONAZOLE 51 24 81 136
NAMENDA 50 50 82 49
PROPRANOLOL HCL 50 27 82 129
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 28, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.